Vascular hyperpermeability in nephrotic edema

Nephron

Volumn 85, Issue 3, 2000, Pages 194-200

  Rostoker, Guy ^b   Behar, Abraham ^a   Lagrue, Gilbert ^a  

^a Hopital Albert Chenevier   (France)

^b Ctr Hosp Prive Claude Galien 20   (France)

Author keywords

Capillary hyperpermeability; Cyclic edema; Idiopathic membranous nephropathy; Idiopathic nephrotic syndrome; Landis isotopic test; Membranoproliferative glomerulonephritis; Minimal change glomerulopathy; Nephrotic edema; Nephrotic syndrome; Vascular permeability

Indexed keywords

ALBUMIN TC 99M; GINKGO BILOBA EXTRACT; METHYLPREDNISOLONE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GLOMERULOSCLEROSIS; HUMAN; KIDNEY SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0033919927     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045661     Document Type: Article

References (29)

1. Cameron S, Glassock R: The Nephrotic Syndrome. London, Churchill Livingstone, 1987.
2. Bernard D: Extrarenal complications of the nephrotic syndrome. Kidney Int 1988;33:1184-1202.
3. Palmer B, Alpern R: Pathogenesis of edema formation in the nephrotic syndrome. Kidney Int 1997;51(suppl 59):21-27.
4. Van de Walle J, Donckerwolcke R, Van Isselt J, Derkx F, Joles J, Koomans H: Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 1995;346:148-152.
5. Perico N, Remuzzi G: Edema of the nephrotic syndrome: The role of the atrial peptide system. Am J Kidney Dis 1993;22:355-366.
6. Taylor A: Capillary fluid filtration: Starling forces and lymph flow. Circ Res 1981;49:557-575.
7. Behar A, Tournoux A, Baillet J, Lagrue G: Untersuchungen zur Bestimmung der kapillaren Durchlässigkeit mit markiertem menschlichem Albumin. Nuklearmedizin 1976;15:214-216.
8. Edwards O, Bayliss R: Idiopathic cyclic oedema of women: A clinical and investigative study. Q J Med 1976;45:125-144.
9. Behar A, Baillet J, Lagrue G: Une nouvelle méthode de mesure de la perméabilité capillaire par méthode isotopique. J Mal Vasc 1977; 2:101-104.
10. Lagrue G, Behar A, Kazandjian M, Rahbar K: Œdèmes cycliques idiopathiques: Rôle de l'hyperperméabilité capillaire et correction par extrait de Ginkgo biloba. Presse Méd 1986;15: 1550-1553.
11. Behar A, Lagrue G, Cohen-Boulakia F, Baillet J: Capillary filtration in idiopathic cyclic edema: Effects of Daflon 500 mg. Nuclearmedizin 1988;27:105-107.
12. Matthews DE, Farewell V: Using and Understanding Medical Statistics. Basel, Karger, 1985.
13. Weil B, Lagrue G, Ménard J: Le syndrome d'œdèmes cycliques idiopathiques. III. Etudes biologiques, déductions physiopathologiques et thérapeutiques. J Urol Néphrol 1971;12:940-952.
14. 131I labelled albumin from the subcutaneous tissue. J Clin Lab Invest 1960;40: 222-223.
15. Wraight E: Capillary permeability of protein as a factor in control of plasma volume. J Physiol (Lond) 1974;237:39.
16. Hilsted J: Dual effect of insulin on plasma volume and transcapillary albumin transport. Diabetologia 1992;35:99-103.
17. Cottran R, Pober J, Gimbrione M: Endothelial activation during interleukin 2 immunotherapy: A possible mechanism for the vascular leak syndrome. J Immunol 1987;139:1883-1888.
18. Royall J, Berkow R, Beckman J, Cunningham M, Matalon S, Freeman B: Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. Am J Physiol 1989; 257:L399-L410.
19. Lagrue G, Xheneumont S, Branellec A, Hirbec G, Weil B: A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome. Biomedicine 1975;23:37-40.
20. Shalhoub R: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974;ii: 556-560.
21. Heslan JM, Branellec A, Laurent J, Lagrue G: The vascular permeability factor is a T lymphocyte product. Nephron 1986;42:187-188.
22. Sobel A, Branellec A, Blanc C, Lagrue G: Physicochemical characterization of vascular permeability factor produced by ConA-stimulated human lymphocytes. J Immunol 1977;119: 1230-1234.
23. Heslan JM, Branellec A, Pilatte Y, Lang P, Lagrue G: Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome. Clin Exp Immunol 1991;86:157-162.
24. Boulton-Jones JM, Tulloch I, Dore B, McClay A: Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 1983;20:72-77.
25. Boulton-Jones JM, McWilliams G, Chandrachud L: Variation in charge on red cells of patients with different glomerulopathies. Lancet 1986;ii:186-189.
26. Levin M, Smith C, Walters MDS, Gascoine P, Barrat TM: Steroid-responsive nephrotic syndrome: A generalised disorder of membrane negative charge. Lancet 1985;ii:239-242.
27. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP: Effect of plasma protein absorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994;330:7-14.
28. Rostoker G, Rymer JC, Bagnard G, Griuncelli M, Petit-Phar M, Pilatte Y: Imbalances in serum proinflammatory cytokines and their soluble receptors: A putative role in the progression of idiopathic IgA nephropathy and Henoch-Schönlein purpura nephritis and a potential target of immunoglobulin therapy? Clin Exp Immunol 1998;114:468-476.
29. Matsumoto K, Kanmatsuse K: Increased IL-12 release by monocytes in nephrotic patients. Clin Exp Immunol 1999;117:361-367.